Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
AbbVie shares rise with extension of RINVOQ patent protection to 2037
01:26pm, Thursday, 11'th Sep 2025
Abbvie Inc (NYSE:ABBV) shares moved higher after the pharma company announced it has secured extended patent protection for its blockbuster autoimmune drug RINVOQ (upadacitinib). It said in a regulato
AbbVie shares hit record high as key immunology drug set for exclusivity until 2037
12:25pm, Thursday, 11'th Sep 2025
AbbVie shares rose 4% to a record high on Thursday after the U.S. drugmaker said it expected no generic competition for its blockbuster immunology drug Rinvoq until 2037, a four-year extension, accord
AbbVie in Settlement With Generic Drugmakers on Rinvoq
12:17pm, Thursday, 11'th Sep 2025
The biopharmaceutical company doesn't expect U.S. generic entry for the drug before 2037 now that it has settled litigation.
Why AbbVie Stock Is Jumping Today
11:50am, Thursday, 11'th Sep 2025
Shares of AbbVie (ABBV 3.95%) were jumping 4.2% higher as of 11:37 a.m. ET on Thursday.
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Thursday, 11'th Sep 2025
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Why Is AbbVie Stock Trading Higher On Thursday?
09:55am, Thursday, 11'th Sep 2025
AbbVie Inc. ABBV stock is trading higher on Thursday following an SEC filing that settled litigation with all generic manufacturers, which filed abbreviated new drug applications with the U.S. Food an
AbbVie: What's Happening With ABBV Stock?
09:45am, Thursday, 11'th Sep 2025
AbbVie's stock is on the rise, and for good reason! The company just reached a major agreement with generic drug manufacturers to delay the release of a generic version of its blockbuster drug, Rinvoq
AbbVie Inc. (ABBV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
01:46pm, Tuesday, 09'th Sep 2025
AbbVie Inc. (NYSE:ABBV ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:00 AM EDT Company Participants Robert Michael - CEO & Chairman of the Board Jeffrey Stewart - Exec
BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories
08:00am, Tuesday, 09'th Sep 2025
Building on the brand's 20-year legacy and real-world experience, the original BOTOX® Cosmetic continues to be the most researched and requested product of its kind.1,2 BOTOX® Cosmetic is trusted by
This 3 Stock Portfolio Provides Monthly Income
08:55pm, Monday, 08'th Sep 2025
If investors select their dividend-paying stocks in a structured manner, they can create a portfolio that provides monthly paydays.
AbbVie (ABBV) Stock Dips While Market Gains: Key Facts
08:37pm, Monday, 08'th Sep 2025
AbbVie (ABBV) closed at $210 in the latest trading session, marking a -1.2% move from the prior day.
Calls of the Day: Abbvie, Vertex, Veeva and Vistra
01:47pm, Monday, 08'th Sep 2025
The Investment Committee discuss the latest Calls of the Day.
J&J vs. AbbVie: Which Healthcare Powerhouse Is Better Positioned?
10:15am, Monday, 08'th Sep 2025
ABBV and JNJ face patent cliffs but show resilience with strong pipelines, acquisitions and promising growth drivers.
1 Reason Every Investor Should Know About AbbVie (ABBV)
03:43am, Monday, 08'th Sep 2025
With patent-protected market exclusivity for their products, pharmaceutical companies reliably produce profits that they aren't shy about distributing to shareholders. In an industry already known for
3 Dividend Stocks to Double Up on Right Now
04:51am, Sunday, 07'th Sep 2025
When you're highly confident about your cards in the game of blackjack, you double down. This means that you double your initial bet in exchange for receiving only one additional card.
